Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis

被引：1
作者：
Zimmer, Vincent [1 ]
Lammert, Frank [1 ]
机构：
[1] Univ Saarland, Med Ctr, Dept Med 2, Kirrberger Str, D-66421 Homburg, Germany
来源：
EBIOMEDICINE | 2017年 / 15卷
关键词：
Biliary epithelial cell; Primary biliary cholangitis; Senescence; Treatment response; Ursodeoxycholic acid; CIRRHOSIS;
D O I：
10.1016/j.ebiom.2016.12.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
[31]   Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA [J].
Li, Jia ;
Lu, Mei ;
Zhou, Yueren ;
Bowlus, Christopher L. ;
Lindor, Keith ;
Rodriguez-Watson, Carla ;
Romanelli, Robert J. ;
Haller, Irina, V ;
Anderson, Heather ;
VanWormer, Jeffrey J. ;
Boscarino, Joseph A. ;
Schmidt, Mark A. ;
Daida, Yihe G. ;
Sahota, Amandeep ;
Vincent, Jennifer ;
Wu, Kuan-Han Hank ;
Trudeau, Sheri ;
Rupp, Loralee B. ;
Melkonian, Christina ;
Gordon, Stuart C. .
DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) :4170-4180
[32]   Obeticholic Acid for Primary Biliary Cholangitis [J].
Floreani, Annarosa ;
Gabbia, Daniela ;
De Martin, Sara .
BIOMEDICINES, 2022, 10 (10)
[33]   Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis A meta-analysis [J].
Wang, Zi-Long ;
Song, Kai-Min ;
Jin, Rui ;
Xie, Yan-Di ;
Wang, Yu-Qiong ;
Liu, Zhi-Cheng ;
Feng, Bo .
MEDICINE, 2022, 101 (09) :E28987
[34]   Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia [J].
AlWabel, Ahmed ;
Peedikayil, Musthafa ;
AlNasser, Sulaiman ;
AlHusaini, Khalid ;
AlHekail, Othman ;
Alqahtani, Saleh ;
AlTraif, Ibrahim ;
AlAshgar, Hamad .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2023, 29 (02) :135-140
[35]   Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis [J].
Chapman, Roger W. .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (08) :460-464
[36]   Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid [J].
Han, Weijia ;
Huang, Chunyang ;
Zhang, Qi ;
Tao, Shuhui ;
Hu, Xiaomin ;
Xu, Jianguo ;
Jiang, Ronglong ;
Xu, Bin ;
Liu, Yanmin ;
Hou, Jinlin .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (02)
[37]   Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit [J].
Schattenberg, Joern M. .
GUT, 2020, 69 (08) :1377-1378
[38]   Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population [J].
Alomari, Mohammad ;
Covut, Fahrettin ;
Al Momani, Laith ;
Chadalavada, Pravallika ;
Hitawala, Asif ;
Young, Mark F. ;
Romero-Marrero, Carlos .
JGH OPEN, 2020, 4 (02) :132-139
[39]   Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era Role of Scoring Systems [J].
Goel, Aparna ;
Kim, Woong Ray .
CLINICS IN LIVER DISEASE, 2018, 22 (03) :563-+
[40]   Predicting Risk in Primary Biliary Cholangitis [J].
Eksteen, Bertus .
HEPATOLOGY, 2016, 63 (03) :697-699
12345